Together, these results suggest that the amplification and overexpression of TP63 due to TP53 loss of function causes elevated EFNB1-EPHB4 interaction among epithelial cells, which promotes ESCC progression via accelerated cell cycle and EMT. Here, TP63 is linked to esophageal squamous cell carcinoma.